Published 11 days ago • loading... • Updated 11 days ago
FixMold Miami Expands Laboratory-Grade Mold Testing as New CDC Data Show Invasive Mold Infections Are More Common and More Severe Than Previously Known
The company is adding laboratory-grade testing as CDC data show invasive mold infections are more common and more severe than doctors thought.
On August 10, 2026, FixMold Miami spotlighted its eight-part laboratory testing menu after a first-of-its-kind U.S. Centers for Disease Control and Prevention study found roughly one in three hospitalized patients with invasive mold disease died.
Researchers reviewing cases at four Atlanta-area hospitals from 2020 to 2024 identified about 450 confirmed cases of invasive mold disease; hospitals can expect three to five cases annually per 100 inpatient beds.
FixMold Miami's testing process employs an eight-part laboratory menu identifying specific mold genera and mycotoxins, with every sample processed through Hayes Microbial Consulting to eliminate reliance on visual inspection alone.
South Florida's high humidity, aging housing stock, and large retiree population intersect with a hurricane season running through November, creating conditions researchers flagged as likely to increase mold exposure over time.
Climate-Driven increases in hurricanes, flooding and humidity are expected to expand overall mold exposure, prompting founder Abraham Katz to emphasize the company's laboratory-verified testing for vulnerable populations including older residents and immunocompromised individuals.